Nutra Pharma Corp (NPHC)

[Cobraman]

The Edsel worked. Betamax worked. Both were failures. The ssue is not whether the product works. The issue is whether the product is a success in the market place.

Cobroxin is a failure in the market place. Nyloxin and Cobroxin have no hope to be successes because NPHC has no money or expertise to performa real marketing program. If they did they would not have given XCHO the marketing rights to Cobroxin.

XCHO is a failure with no money or expertise to properly market Cobroxin. Rik knows this, but is stuck because no one else will spend the money to do so.

Nyloxin is a different market and Henry Schein will not spend money on advertizing. The market for Doctors is much smaller than the market for large retail chains. It is tiny and an uphill battle.

Nyloxin will not cannabalize Cobroxin. In short, these products and this company are failures.